Navigation Links
Study Finds Ovarian Screening Tests Don't Improve Survival
Date:5/19/2011

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, May 18 (HealthDay News) -- New research finds that the only two tests available to screen for ovarian cancer don't reduce the average woman's risk of dying from this "silent killer."

Screening with a blood test and then a transvaginal ultrasound might even cause harm, the University of Utah study suggests, since there was a huge number of worrisome false-positive results, subsequent biopsies and resulting complications.

"I am neither surprised nor disappointed. We kind of knew that, but it's nice to have the final results of the study," said one expert, Dr. Karen Lu, a professor of gynecologic oncology at The University of Texas M.D. Anderson Cancer Center in Houston.

"This actually confirms what we've always known," added Dr. Mark Wakabayashi, chief of gynecologic oncology at City of Hope Cancer Center in Duarte, Calif.

The bottom line: there are currently no good screening techniques to detect ovarian cancer early in women who are otherwise healthy, Lu said. Unfortunately, that means that many women are diagnosed at a later stage of the illness, when it is less treatable.

"Most of these cancers are detected late, even in screening trials," Wakabayashi confirmed.

Scientists have long been investigating a blood test for a marker called CA-125, as well as transvaginal ultrasound (TVA).

To test its effectiveness, the Utah authors randomized almost 80,000 women, aged 55 to 74, to either undergo an annual CA-125 screen for six years plus TVA annually for four years, or to "usual care."

After a follow-up of up to 13 years, the researchers found no differences in ovarian cancer diagnoses or mortality rates between the two groups. There were 212 cases of ovarian cancer in the screening group, compared to 176 in the usual care group, and 118 deaths in the screening group compared to 100 in the usual care group.

The researchers plan to present their findings in June at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

Moreover, almost 3,300 women received false positive results from the screens. Almost 1,100 of these women went on to undergo surgical biopsies and 163 had some kind of serious complication, the study found.

Other screening techniques for ovarian cancer are being studied, including a trial led by Lu that looks at whether changes in CA-125 levels over time could pick up malignancies.

However, for the time being, successful screening for ovarian cancer remains elusive.

"This doesn't change anything in terms of standard of care," Lu said. "There is still no successful current effective method to screen for ovarian cancer."

"There's really nothing that's good at this point [for women at average risk]," Wakabayashi said. But, she pointed out that women at high risk for ovarian cancer, such as those carrying the malignancy-linked BRCA gene mutation, should still have their CA-125 checked and undergo ultrasounds.

More information

The U.S. National Cancer Institute has more on ovarian cancer.

SOURCES: Karen Lu, M.D., professor, gynecologic oncology, M.D. Anderson Cancer Center, University of Texas, Houston; Mark Wakabayashi, M.D., chief, gynecologic oncology, City of Hope Cancer Center, Duarte, Calif.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pitt researchers build a better mouse model to study depression
2. Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer: Study
3. Electronic medical records lower infant mortality, study finds
4. End-of-Life Care Differs Between U.S., Canada, Study Finds
5. Massachusetts Study Shows Sharp Rise in Early Autism Diagnoses
6. Rise of for-profit hospice industry raises troubling questions, new study says
7. Dairy consumption does not elevate heart-attack risk, study suggests
8. Scientific study proves that goat milk can be considered as functional food
9. Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds
10. Hospitals misleading patients about benefits of robotic surgery, study suggests
11. Pills, Surgery Both Effective for Chronic Reflux: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Ovarian Screening Tests Don't Improve Survival
(Date:5/25/2016)... ... 25, 2016 , ... TransactRx announces the release of enhanced ... service claims by Pharmacy Benefit Managers that were submitted by Retail Clinics and ... Cross Benefit Clearinghouse receives standard professional medical claims submitted from the retail clinic’s ...
(Date:5/25/2016)... ... May 25, 2016 , ... The University of San Francisco ... Professions. She will lead a team of more than 100 full-time faculty and staff, ... role as dean in late August. , Baker comes to USF from the University ...
(Date:5/25/2016)... FLA (PRWEB) , ... May 25, 2016 , ... ... technology to help turn back the hands of time of female aging. The ... and childbirth. Women with symptoms such as leakage, laxity, itchiness and pain have ...
(Date:5/25/2016)... Pine Brook, NJ (PRWEB) , ... May 25, 2016 , ... ... at the 2016 Annual COVD Meeting for their work on visual evoked potential and ... , summarizes recent studies that used the Diopsys® NOVA™ ERG and VEP Vision ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... builder, has announced that it will join America's leading engineers at the American ... held at the Georgia World Congress Center. , Engineers, speakers and exhibitors ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 Los innovadores ... del mundo, introduce catéteres para la intervención de ... una compañía global especializada en el suministro de ... su cartera incluyendo productos para tratar la enfermedad ... PTA son los dispositivos de primera entrada de ...
(Date:5/23/2016)... India , May 23, 2016 ... report "Patient Handling Equipment Market by Product (Wheelchair, ... of Care (Bariatric Care, Critical Care, Wound), Accessories ... - Forecast to 2021", published by MarketsandMarkets, the ... USD 17.18 Billion by 2021 at a CAGR ...
(Date:5/23/2016)... Clarifying Vision - Prospects and ... Vision Care What can be expected from ... grow at the fastest rates? This visiongain ... trends, opportunities and prospects. ,Our 190-page ... most lucrative areas in the industry and the future ...
Breaking Medicine Technology: